Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Post-Market Clinical Follow-up (PMCF) Study of the Pitch-Patch for the Augmentation or Reinforcement of the Rotator Cuff

Sponsor: Xiros Ltd

NCT ID: NCT05906004

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Pitch-Patch (device)
How long the study runs
Study runs about 42 months (dates as stated)
About the drug or intervention
Pitch-Patch — device: Pitch-Patch device used for rotator cuff augmentation/ reinforcement.
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
16 Years and over
Who
All
Number of participants
37
Started
2026-06-16
Last checked
2026-09

Plain English Summary

What is this study?

  • • Testing a new treatment for rotator cuff tear
  • • Clinical study - 37 participants
  • • This is a clinical investigation study

Who can take part?

  • • Ages 16 Years and over
  • • Diagnosed with rotator cuff tear

Where?

  • • Reading - Reading Shoulder Unit

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

This is a clinical investigation study. It will verify the long-term safety and performance of the Pitch-Patch when implanted to reinforce partially repairable rotator cuff tears and used as described by the manufacturer's instructions. The medical device in this study is already on the market and is manufactured by Xiros Ltd. The Pitch-Patch is a single-use polyester prosthesis available in two sizes (30x20mm and 35x25mm). It is reinforced around the perimeter and around each eyelet to provide strength and stability to the device and repair. The study will collect data on patients who meet the entry criteria and have received the device. This is a single-armed study, meaning all patients will have a Pitch-Patch. The total length of the study is expected to be 3 years. A minimum of 37 patients will be enrolled into the study. Patients will be enrolled at a study specific follow up visit 2-2.5 years after implant, and data for baseline, procedure, and other time points prior to 2 years (3month, 6month, and 1 year post surgery) will be collected retrospectively from medical records if available.

More detail

This is a clinical investigation study with both a prospective and retrospective study design. It will verify the long-term safety and performance of the Pitch-Patch when implanted to reinforce partially repairable rotator cuff tears and used as described by the manufacturer's instructions. The medical device in this study is already on the market and is manufactured by Xiros Ltd. The Pitch-Patch is a single-use polyester prosthesis available in two sizes (30x20mm and 35x25mm). It is reinforced around the perimeter and around each eyelet to provide strength and stability to the device and repair. The study will collect data on patients who meet the entry criteria and have received the device. This is a single-armed study, meaning all patients will have a Pitch-Patch. The total length of the study is expected to be 3 years. A minimum of 37 patients will be enrolled into the study. Patients will be enrolled at a study specific follow up visit 2-2.5 years after implant, and data for baseline, procedure, and other time points prior to 2 years (3month, 6month, and 1 year post surgery) will be collected retrospectively from medical records if available.

Rotator Cuff TearRotator Cuff TearsRotator Cuff Tears of the ShoulderRotator Cuff Injuries

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 16 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Patient has been treated using a Pitch-Patch device for augmentation or reinforcement of the rotator cuff 2-2.5years...
  • ✓Patient has a baseline Constant Murley Score (CMS), assessed within 30 days prior to implantation of the device.
  • ✓Patient must be 16 years old or above.
  • ✓Patient is willing to participate in the study, and having been informed of the nature of the study, has provided...

Who cannot take part

  • ✗\- The Pitch-Patch has been used outside its intended use.
See the full criteria
Inclusion Criteria: * Patient has been treated using a Pitch-Patch device for augmentation or reinforcement of the rotator cuff 2-2.5years prior to enrolment. * Patient has a baseline Constant Murley Score (CMS), assessed within 30 days prior to implantation of the device. * Patient must be 16 years old or above. * Patient is willing to participate in the study, and having been informed of the nature of the study, has provided written informed consent as approved by the Ethics Committee (EC). Exclusion Criteria: \- The Pitch-Patch has been used outside its intended use.

Where Is This Study? (1 UK site)

Reading Shoulder Unit

Reading RG1 6UZ, United Kingdom

Recruiting
Site contact (verified)
Ofer LevyPrincipal Investigator

How to Get in Touch

Lisa Cook

Sponsor contact

CONTACT

+44 (0) 113 238 7200 lisa.cook@xiros.co.uk

Vikki Adams

Sponsor contact

CONTACT

07825626018 vikki.adams@xiros.co.uk
Data sourced from ClinicalTrials.gov · Last verified: 2026-09